Android app on Google Play

Medicis Pharmaceutical Corp. (MRX) Reports Slightly Better-Than-Expected Q4 Results

February 27, 2012 4:07 PM EST Send to a Friend
Medicis Pharmaceutical Corp. (NYSE: MRX) reported Q4 EPS of $0.56, $0.01 better than the analyst estimate of $0.55. Revenue for the quarter came in at $180.7 million versus the consensus estimate of $179.2 million.

For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment